Taken together, these findings shed light on the intricate mechanisms through which blocking sclerostin can influence Wnt signaling, tumor sphere formation, and osteoclastogenesis in the context of bone metastasis, particularly in breast cancer cells that exhibit a strong response to Wnt ligands like Wnt3a. The gene discussed is WNT3A; the disease is breast cancer.